David Scott Metzger, Ph.D.
 
	    		Research Professor of Social Policy in Psychiatry
          Director, HIV Prevention Research Division, Department of Psychiatry, Perelman School of Medicine
              Director, Behavioral and Social Sciences Core, Center for AIDS Research, Perelman School of Medicine
              Co-Director, Penn Mental Health AIDS Research Center, Perelman School of Medicine
              Director, Developmental Core, Penn Mental Health AIDS Research Center,  Perelman School of Medicine
          Department: Psychiatry
	  
		  
	    Contact information
	    
	  
		
		
		  HIV Prevention Research Division
3535 Market Street Rm. 4001
Philadelphia, PA 19104
Philadelphia, PA 19104
	    3535 Market Street Rm. 4001
Philadelphia, PA 19104
Philadelphia, PA 19104
	    	      	      Office: 267-566-2483
Fax: 215-746-7377
	      	    	      	    	    
	              Fax: 215-746-7377
Email: 
dsm@pennmedicine.upenn.edu
        	  dsm@pennmedicine.upenn.edu
	    Publications
	    
	  
		
	
	  	  
	  
         	
	  
		Education:
B.A. (Psychology)
Stockton State College , 1975.
M.S. (Applied Research)
Hahnemann University , 1977.
Ph.D. (Social Policy Analysis)
Rutgers University, 1987.
 
			  
	 
		
		
		
	  	  Permanent linkB.A. (Psychology)
Stockton State College , 1975.
M.S. (Applied Research)
Hahnemann University , 1977.
Ph.D. (Social Policy Analysis)
Rutgers University, 1987.
Selected Publications
Meanley S, Carter WB, Short WR, Metzger DS, Onorato A, Montaner LJ, Dubé K.: HIV Clinical Providers' Awareness, Attitudes, and Willingness to Support Patient Outreach Efforts for HIV Cure-Directed Research in Philadelphia, United States. Open Forum Infect Dis. 12(11), Nov 2024.Herrera MC, Johnson J, Lim S, Morales KH, Wilson JD, Hadland SE, Metzger D, Wood S, Dowshen N.: Co-delivery of HIV pre-exposure prophylaxis (PrEP) and HIV testing among publicly insured adolescents and young adults (AYA) receiving medication for opioid use disorder (MOUD). Drug Alcohol Depend. 257, April 2024.
Goodman-Meza D, Shoptaw S, Hanscom B, Smith LR, Andrew P, Kuo I, Lake JE, Metzger D, Morrison EAB, Cummings M, Fogel JM, Richardson P, Harris J, Heitner J, Stansfield S, El-Bassel N; HPTN 094 Study Team.: Delivering integrated strategies from a mobile unit to address the intertwining epidemics of HIV and addiction in people who inject drugs: the HPTN 094 randomized controlled trial protocol (the INTEGRA Study). Trials 15(25), Feb 2024.
Stewart RE, Christian HP, Cardamone NC, Abrams C, Drob C, Mandell DS, Metzger D, Lowenstein M.: Mobile service delivery in response to the opioid epidemic in Philadelphia. Addict Sci Clin Pract 18: 71, Nov 2023.
Bilger A, Plenn E, Barg FK, Rendle KA, Carter WB, Lamour-Harrington A, Jones N, Peterson B, Sauceda JA, Tebas P, Mounzer K, Metzger D, Montaner LJ, Dubé K.: Participant experiences in HIV cure-directed trial with an extended analytical treatment interruption in Philadelphia, United States. HIV Res Clin Pract 24: 2267825, Oct 2023.
Kreider EF, Ortega-Burgos Y, Dumeng-Rodriguez J, Gesualdi J, O'Brien C, Bracy D, Johnson J, Bowman J, Metzger D, Dine CJ, Favor K, Jordan-Sciutto KL, Momplaisir F.: Early Engagement in HIV Research: Evaluation of the Penn CFAR Scholars Program Aimed at Increasing Diversity of the HIV/AIDS Workforce. J Acquir Immune Defic Syndr 94: S28-S35, Oct 2023.
Dumchev K, Guo X, Ha TV, Djoerban Z, Zeziulin O, Go VF, Sarasvita R, Metzger DS, Latkin CA, Rose SM, Piwowar-Manning E, Richardson P, Hanscom B, Lancaster KE, Miller WC, Hoffman IF.: Causes and risk factors of death among people who inject drugs in Indonesia, Ukraine and Vietnam: findings from HPTN 074 randomized trial. BMC Infect Dis 23: 319, May 2023.
Herrera MC, Darien K, Wood S, Hadland SE, Metzger D, Dowshen N.: A Qualitative Study of Barriers and Facilitators to Integrating Medications for Opioid Use Disorder and HIV Preexposure Prophylaxis for Adolescents and Young Adults. J Addict Med 2023.
Neergaard R, Jones NL, Roebuck C, Rendle KA, Barbati Z, Peterson B, Tebas P, Mounzer K, Metzger D, Montaner LJ, Dube K, Barg FK.: "I Know That I Was a Part of Making a Difference": Participant Motivations for Joining a Cure-Directed HIV Trial with an Analytical Treatment Interruption. AIDS Res Hum Retroviruses 2023.
Yuh T, Srivastava T, Fiore D, Schmidt H, Frank I, Metzger D, Momplaisir F.: Using a patient portal as a recruitment tool to diversify the pool of participants in COVID-19 vaccine clinical trials. JAMIA Open 5: ooac091, Nov 2022.
